00:00 Introduction
\nSpeakers:
\nVikram Dendi, Chief Product Officer, Microsoft Health Futures
\nJim Weinstein, Senior Vice President, Microsoft Research & Incubations<\/p>\n
07:04 Panel Discussion
\nModerator: Miah Wander, Principal Researcher, Microsoft Health Futures
\nSpeakers:
\nAnn Aerts, Head of Novartis Foundation, Novartis
\nElena Bonfiglioli, Regional Leader, Microsoft Health Futures
\nDr. Sujoy Kar, Chief Medical Information Officer & Vice President, Apollo Hospitals<\/p>\n
Cardiovascular disease (CVD) presents an immense health challenge globally and for the United States, as it is the leading cause of death and a salient example of racially biased healthcare research. At the same time, effective treatments developed in the last few decades nearly halved deaths due to stroke and heart disease. Moreover, successful clinical interventions, delivery models, and policy efforts have achieved measurable positive impacts within a year at the population level, making it the site of enormous medical advancement, innovation, and potential impact. Join us for this panel of thought leaders and practitioners in this space who will discuss this high-impact opportunity to engage proven advances in science and technology and combat health inequities. Discover how the combination of scale and treatment potential makes CVD an interesting launching pad for technology platforms to combat disparities in disease research and treatment.<\/p>\n